Increase in brain tumors is not attributed to mobile phone use
the ONA take:
New research from the University of Auckland found that risk of brain cancer is not increased by mobile phone use. Concerns have been raised about whether use of mobile phones can increase the incidence of brain cancers.
Previous studies from around the world reported findings that showed no risk or a slightly increased risk, with some studies suggesting a substantial risk.
The New Zealand team examined the frequency of brain cancers in total and in subtypes highlighted in other studies, using data from the New Zealand cancer registry.
These investigators found no general increase. They did see, however, was a decrease of approximately 1% per year in people 10 to 69 years. Based on their findings, they report previous findings of large increases in risk are likely to be incorrect.
However, they concede that a study of this type cannot exclude a small risk, or one limited to certain subtypes of cancers, or a risk arising after more than 15 years of phone use.
The research team cannot explain the decrease in brain cancers in New Zealand. An increase in some types of brain cancer among people 70 years and older—in New Zealand and other countries—may be related to improved diagnosis.
Brain cancer is not increased by mobile phone use.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|